Newly minted NuVasive CEO Greg Lucier has quite the pedigree when it comes to building successful companies. Lucier, who was named permanent CEO of the San Diego, Calif.-based spinal device company in May 2015, built Life Technologies from a start up (then named Invitrogen) to a global biotech juggernaut with 12,000 employees and just under […]
Thermo Fisher Scientific
FTC OKs Thermo Fisher’s Life Technologies buy pending asset sale to GE Healthcare
China wants concessions in Thermo Fisher’s $13.6B Life Tech deal
GE Healthcare offers $1.06B for trio of Thermo Fisher lifesciences units
Cook Medical continues to shuffle management | Personnel Moves
Cook Medical named Rob Lyles executive vice president, the latest move in a larger management shift at the Indiana medtech maker.
Lyles was formerly vice president of Cook’s peripheral intervention division. He has been with the company since 2003 and was named division VP in 2007. Lyles’ promotion follows the advancement of Pete Yonkman to president of the Cook Medical. Mark Breedlove, a 19-year veteran of Cook Medical, will succeed Lyles as VP of the peripheral intervention division.
Thermo Fisher agrees to $13.6B Life Technologies buyout
Medtech M&A Madness | Wall Street Beat
Acquisitions: Thermo Fisher buys Colo. spectrometer maker
Thermo Fisher Scientific Inc. (NYSE:TMO) has acquired Boulder, Colo.-based picoSpin for an undisclosed amount.
The Waltham, Mass.-based Thermo Fisher will fold picoSpin into its chemical analysis business as part of the Analytical Technologies business unit, according to a prepared release.
Device makers lack green initiative, report says | MassDevice.com On Call
MASSDEVICE ON CALL — A look at the top 10 medical device makers found that more than half had little to no environmental initiatives in place.
In a study conducted by Green Research, the companies with stainability initiatives were:
India a tempting prospect for med-tech manufacturing | MassDevice.com On Call
MASSDEVICE ON CALL — As manufacturing costs rise in western nations, BRIC countries like India and China become more alluring for med-tech makers, well-known cardiologist and professor Dr. Balram Bhargava told a Cambridge University lecture.
"There is a thinning medical pipeline in the west," Bhargava said. "Innovation centres are developing in these countries and they will probably develop devices that will ultimately be accepted by the west, be partnered by the west and therefore western companies will move to Indian soil to manufacture."
European commission gives Thermo Fisher’s $3.5 billion Phadia buyout the green light | MassDevice.com On Call
MASSDEVICE ON CALL — The European Commission in Brussels cleared Thermo Fisher Scientific Inc.’s (NYSE:TMO) $3.5 billion cash buyout of Swedish blood test maker Phadia, finding that "the transaction would not raise competition concerns."
"After investigating the proposed transaction, the Commission determined that the parties are not close competitors and are currently primarily constrained by other competitors, which would continue to constrain the merged entity," according to a press release.